USD 14.1
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 250 Million USD | 15.9% |
2022 | 215.7 Million USD | 187.6% |
2021 | 75 Million USD | -25.0% |
2020 | 100 Million USD | -33.33% |
2019 | 150 Million USD | 133.28% |
2018 | 64.3 Million USD | 36.23% |
2017 | 47.2 Million USD | 6.31% |
2016 | 44.4 Million USD | -27.92% |
2015 | 61.6 Million USD | -9.14% |
2014 | 67.8 Million USD | 11.19% |
2013 | 60.97 Million USD | 60.98% |
2012 | 37.87 Million USD | 49.93% |
2011 | 25.26 Million USD | -41.23% |
2010 | 42.99 Million USD | 43.33% |
2009 | 29.99 Million USD | 40233.63% |
2008 | 74.36 Thousand USD | -82.14% |
2007 | 416.42 Thousand USD | -96.85% |
2006 | 13.21 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 335.5 Million USD | 0.0% |
2023 FY | 250 Million USD | 15.9% |
2023 Q2 | 300 Million USD | -5.72% |
2023 Q3 | 280.4 Million USD | -6.53% |
2023 Q4 | 250 Million USD | -10.84% |
2023 Q1 | 318.2 Million USD | 47.52% |
2022 Q3 | 215.7 Million USD | -20.93% |
2022 FY | 215.7 Million USD | 187.6% |
2022 Q4 | 215.7 Million USD | 0.0% |
2022 Q1 | 272.8 Million USD | 45.8% |
2022 Q2 | 272.8 Million USD | 0.0% |
2021 FY | 75 Million USD | -25.0% |
2021 Q3 | 187.1 Million USD | -9.35% |
2021 Q2 | 206.4 Million USD | 0.0% |
2021 Q1 | 206.4 Million USD | 6.34% |
2021 Q4 | 187.1 Million USD | 0.0% |
2020 Q2 | 156.4 Million USD | 0.0% |
2020 FY | 100 Million USD | -33.33% |
2020 Q3 | 194.1 Million USD | 24.1% |
2020 Q4 | 194.1 Million USD | 0.0% |
2020 Q1 | 156.4 Million USD | -30.18% |
2019 Q4 | 224 Million USD | 0.0% |
2019 Q3 | 224 Million USD | 294.37% |
2019 FY | 150 Million USD | 133.28% |
2019 Q2 | 56.8 Million USD | 0.0% |
2019 Q1 | 56.8 Million USD | -11.66% |
2018 Q2 | 61.2 Million USD | 0.0% |
2018 Q3 | 64.3 Million USD | 5.07% |
2018 Q4 | 64.3 Million USD | 0.0% |
2018 Q1 | 61.2 Million USD | 29.66% |
2018 FY | 64.3 Million USD | 36.23% |
2017 Q2 | 55.4 Million USD | -4.81% |
2017 FY | 47.2 Million USD | 6.31% |
2017 Q4 | 47.2 Million USD | -22.75% |
2017 Q3 | 61.1 Million USD | 10.29% |
2017 Q1 | 58.2 Million USD | 31.08% |
2016 Q1 | 54.4 Million USD | -11.69% |
2016 FY | 44.4 Million USD | -27.92% |
2016 Q4 | 44.4 Million USD | -54.51% |
2016 Q3 | 97.6 Million USD | 94.04% |
2016 Q2 | 50.3 Million USD | -7.54% |
2015 Q4 | 61.6 Million USD | 5.3% |
2015 FY | 61.6 Million USD | -9.14% |
2015 Q3 | 58.5 Million USD | -10.55% |
2015 Q1 | 212.3 Million USD | 213.13% |
2015 Q2 | 65.4 Million USD | -69.19% |
2014 Q4 | 67.8 Million USD | 24.64% |
2014 FY | 67.8 Million USD | 11.19% |
2014 Q3 | 54.39 Million USD | 19.95% |
2014 Q2 | 45.35 Million USD | -8.13% |
2014 Q1 | 49.36 Million USD | -19.05% |
2013 Q2 | 32.72 Million USD | -3.3% |
2013 FY | 60.97 Million USD | 60.98% |
2013 Q4 | 60.97 Million USD | 31.92% |
2013 Q3 | 46.22 Million USD | 41.25% |
2013 Q1 | 33.84 Million USD | -10.66% |
2012 Q3 | 23.77 Million USD | -8.29% |
2012 FY | 37.87 Million USD | 49.93% |
2012 Q1 | 16.84 Million USD | -33.34% |
2012 Q2 | 25.92 Million USD | 53.93% |
2012 Q4 | 37.87 Million USD | 59.34% |
2011 Q2 | 30.42 Million USD | -48.99% |
2011 Q1 | 59.65 Million USD | 38.75% |
2011 Q4 | 25.26 Million USD | 19.1% |
2011 FY | 25.26 Million USD | -41.23% |
2011 Q3 | 21.21 Million USD | -30.29% |
2010 Q1 | 22.68 Million USD | -24.39% |
2010 FY | 42.99 Million USD | 43.33% |
2010 Q4 | 42.99 Million USD | 8.58% |
2010 Q3 | 39.59 Million USD | 139.08% |
2010 Q2 | 16.55 Million USD | -26.99% |
2009 FY | 29.99 Million USD | 40233.63% |
2009 Q4 | 29.99 Million USD | 0.0% |
2008 FY | 74.36 Thousand USD | -82.14% |
2007 FY | 416.42 Thousand USD | -96.85% |
2006 FY | 13.21 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Ameriprise Financial, Inc. | 170.46 Billion USD | 99.853% |
Gladstone Investment Corporation | 445.37 Million USD | 43.867% |
Principal Financial Group, Inc. | 293.83 Billion USD | 99.915% |
Africa Opportunity Fund Limited | 160.69 USD | -155578965.281% |
BH Macro Limited | 3 Million USD | -8230.556% |
BioPharma Credit PLC | 15.87 Million USD | -1475.2% |
CATCo Reinsurance Opportunities Fund Ltd. | 2.44 Million USD | -10114.091% |
Craven House Capital Plc | 1.56 Million USD | -15905.122% |
JPEL Private Equity Limited | 623 Thousand USD | -40028.411% |
Pershing Square Holdings, Ltd. | 3.06 Billion USD | 91.846% |
Ecofin U.S. Renewables Infrastructure Trust PLC | 795 Thousand USD | -31346.541% |
RTW Venture Fund Limited | 17.21 Million USD | -1352.52% |
Tufton Oceanic Assets Limited | 1.2 Million USD | -20603.128% |
Symphony International Holdings Limited | 425 Thousand USD | -58723.529% |
Taylor Maritime Investments Limited | 3.4 Million USD | -7249.334% |
TMT Investments PLC | 1.71 Million USD | -14453.363% |
Third Point Investors Limited | 333.38 Thousand USD | -74889.277% |